Table 3.

The relationship between ADAMTS8, ADAMTS18 and ADAMTS20 protein expressions and clinical pathology parameters of IDC.

Parameter	Cases	ADAMTS8		ADAMTS18		ADAMTS20
		Positive	P	Positive	P	Positive	P
Histological grade
I	17	82.4% (14/17)		76.5% (13/17)		88.2% (15/17)
II–III	261	84.7% (221/261)	0.568	95.0% (248/261)	0.002*	54.0% (141/261)	0.006*
Tumor size (cm)
≤2	154	83.1% (128/154)		87.7% (135/154)		70.8% (109/154)
>2	124	86.3% (107/124)	0.558	90.3% (112/124)	0.651	74.2% (92/124)	0.635
Age (year)
<50	136	83.1% (113/136)		87.5% (119/136)		70.6% (96/136)
≥50	142	86.0% (122/142)	0.558	90.1% (128/142)	0.651	74.0% (105/142)	0.635
Lymphatic metastasis
No	105	88.6% (93/105)		87.6% (92/105)		70.5% (74/105)
Yes	173	82.1% (142/173)	0.16	89.0% (154/173)	0.825	73.4% (127/173)	0.753

^*P<0.05 indicated statistical significance.